Health Care & Life Sciences » Pharmaceuticals | JW Pharmaceutical Corp.

JW Pharmaceutical Corp. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
394,182
412,791
434,352
467,465
502,919
537,182
Cost of Goods Sold (COGS) incl. D&A
244,792
262,428
270,647
295,372
315,786
343,968
Gross Income
149,390
150,363
163,705
172,094
187,133
193,214
SG&A Expense
124,382
133,164
142,846
147,556
165,415
171,630
EBIT
25,009
17,199
20,449
-
21,296
21,584
Unusual Expense
1,025
370
1,987
4,285
6,837
2,305
Non Operating Income/Expense
2,072
68
4,580
7,907
5,755
4,779
Interest Expense
20,653
17,282
17,015
14,069
10,727
8,688
Pretax Income
2,843
790
1,901
7,081
1,348
10,234
Income Tax
1,131
414
145
18,015
606
2,177
Equity in Affiliates
563
1,071
380
-
-
-
Consolidated Net Income
2,275
1,447
2,136
10,934
742
8,057
Net Income
2,275
1,447
2,136
10,934
742
8,057
Net Income After Extraordinaries
2,275
1,447
2,136
10,934
742
8,057
Net Income Available to Common
2,275
648
2,136
10,934
742
8,057
EPS (Basic)
157.56
40.10
116.91
572.55
39.00
406.85
Basic Shares Outstanding
14
16
18
19
19
20
EPS (Diluted)
157.56
40.10
116.91
572.55
38.87
406.85
Diluted Shares Outstanding
14
16
18
19
19
20
EBITDA
41,162
33,816
38,312
41,873
39,198
38,531
Other Operating Expense
-
-
411
423
422
-
Non-Operating Interest Income
1,584
571
1,060
561
115
9
Equity in Affiliates (Pretax)
-
-
-
97
560
197
Preferred Dividends
-
799
-
-
-
-

About JW Pharmaceutical

View Profile
Address
JW Tower
Seoul SL 06725
Korea, Republic Of
Employees -
Website http://www.jw-pharma.co.kr
Updated 07/08/2019
JW PHARMACEUTICAL Corp. engages in the development, manufacture, and sale of pharmaceuticals. Its products include analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, antifungal agents, circulatory system agents, gastrointestinal agents, miscellaneous, multivitamins and anti-anemic agents, contact lens care and ophthalmic agents, topicals, amino acid solutions, flexible intravenous container, intravenous solutions, respiratory agents, obstetrics and gynecology agents, nephrology agents, central nervous system, urology agents, and diabetic agents. The company was founded on August 8, 1945 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.